Last modified on 12 January 2007.

Financial Support for This Work:

• National Institutes of Health (Grant #s GM48207 and GM067317, to RRG).
• Isis Pharmaceuticals (to RRG).
• Startup Funds from the University of Texas at Austin (Institute for Cellular and Molecular Biology) (to RRG).
• Welch Foundation (Grant # F-1427, to RRG).
• National Science Foundation (Grant # MCB-0110252, to RRG).
• Microsoft Research (to RRG)